A Pilot Prospective Clinical Trial Using Remote Monitoring for Cancer Patients Undergoing Outpatient Chemotherapy

Description

A pilot study using remote monitoring technology developed by Locus Health in cancer patients undergoing chemotherapy treatment.

Conditions

Solid Tumor, Hematological Malignancy

Talk to us

Study Overview

On this page

Study Details

Study overview

A pilot study using remote monitoring technology developed by Locus Health in cancer patients undergoing chemotherapy treatment.

A Pilot Prospective Clinical Trial Using Remote Patient Monitoring for Cancer Patients Undergoing Outpatient Chemotherapy

A Pilot Prospective Clinical Trial Using Remote Monitoring for Cancer Patients Undergoing Outpatient Chemotherapy

Condition
Solid Tumor
Intervention / Treatment

-

Contacts and Locations

Fairfax

Inova Schar Cancer Institute, Fairfax, Virginia, United States, 22031

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Planned to be treated with a new cytotoxic chemotherapy or chemoimmunotherapy regimen for a solid tumor or malignant hematology condition for at least 4 months
  • * ECOG performance status of 0-2
  • * Age of 18 or older patient with any solid tumor or hematologic malignancy
  • * English or Spanish speaker
  • * Own an Apple iPhone
  • * Capacity and willingness to provide informed consent
  • * Patients undergoing concurrent radiation since they will be seen on a daily basis by clinic care teams and are not likely to benefit from active remote patient monitoring
  • * Patients unwilling or unable to comply with the protocol, including wearing the Apple Watch (including recharging daily) and answering queries on the Locus Health iPhone application per the protocol and study group cadence
  • * Any condition for which in the Investigator's opinion would limit compliance with study requirements

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Inova Health Care Services,

John Deeken, MD, PRINCIPAL_INVESTIGATOR, Inova Schar Cancer Institute

Study Record Dates

2025-11-26